PEG-MGF
IGF-1 splicing variant (MGF) with added Polyethylene Glycol (PEG) for stability. Activates muscle satellite cells, promoting fusion and repair after mechanical damage.
- Activation of satellite cells (Repair)
- Recovery from local muscle/tendon injuries
- Reduction of local post-trauma inflammation
- Neuroprotection (research)Activation of satellite cells (Repair)
- Neuroprotection (research)
- Hypoglycaemia (less risk than IGF-1), local pain.
PEG-MGF (Pegylated Mechano-Growth Factor) is a variant of IGF-1 resulting from the splicing of the gene, modified with polyethylene glycol to increase its stability and duration in the body.
READ MORE
What it is (in plain language)
- MGF is the signal your muscles produce when they are damaged by exercise to recruit 'satellite cells' for repair. The 'PEG' version allows this signal to last much longer in the blood, forcing the body to repair and build muscle fibres much more aggressively than normal.
Why do you appear online so much
- It is a favourite for post-workout recovery and for healing muscle injuries quickly. It is highly valued by athletes who need to maintain or increase muscle mass while dealing with high-frequency, high-volume workouts.
How it is framed today (pragmatic view)
- 1) Evidence: Well documented in skeletal muscle biology. 2) Purpose: Hypertrophy and repair of tissue damage. 3) Risk: May cause mild hypoglycaemia; timing of administration is crucial.
How to use this form
- Check the 'Handling Notes' section to understand why this peptide must be kept strictly refrigerated.
- Quick profile (curated by Subject 157)
- Class: Repair
- Status: Verified
- Use case: Repair
- Route: Injectable
- Tags: Injectable|Muscle|Recovery
- Half-life: ~48-72 Hours
- Start: Slow
- Duration: Days
- Mechanism (high level)
IGF-1 splicing variant (MGF) with added Polyethylene Glycol (PEG) for stability. Activates muscle satellite cells, promoting fusion and repair after mechanical damage.
- Evidence (what the literature covers)
RESEARCH RANGE (Non-prescriptive):
200mcg to 400mcg applied locally or systemically after training/injury.
Level of Evidence: C.
- Safety and harm-reduction (non-prescriptive)
Risks: Hypoglycaemia (less risk than IGF-1), local pain.
Interactions: Unknown.
- References (anchors)
- Matheny, R. W. (2010) - Mechano-growth factor in muscle repair and signalling - https://doi.org/10.1210/en.2009-1217
- Goldspink, G. (2013) - PEG-MGF and muscle cell signalling - https://doi.org/10.1007/s11010-013-1689-4 | PubMed:23756857
Note: Educational/research content. Does not constitute medical advice, diagnosis or prescription.
